Levo uses neuroscience-based therapy to reduce a patient’s tinnitus over time. Its FDA-cleared, patented and proprietary software solution generates a customized, individualized acoustic recipe (IAR) that precisely matches the sound the patient is hearing. The patient will listen to their IAR at night for up to 8 hours throughout the 9 months of therapy to induce neuroplastic changes in the brain. Those changes will lead to a consistent and lasting tinnitus intensity reduction over time and strongly correlate with an overall improvement in quality of life.

The therapy consists of 3 phases, Adaptation, Continuous Stimulation, and Detachment/Maintenance. It is recommended that the Levo systems be used for up to 9 months in order to see long term benefits.

It is recommended that the Levo systems be used for up to 9 months for the potential to see long term benefits.

However, an independent study published featuring the Levo System found that the majority of patients saw improvements after the first 3 months of therapy. Additionally, after three months of therapy, another study found that patients experienced an average reduction of tinnitus intensity of 80%. This was accompanied by an average Tinnitus Functional Index (TFI) decrease of 77%.

The Levo System is a medical device that is indicated for use in combination with a counselling protocol established by your healthcare professional. In the event that you are not seeing success, it is recommended that you talk with your healthcare professional prior to discontinuing therapy. Your healthcare professional may review the therapy usage and volume evolution reports stored on your device to help inform if changes to the protocol or sound match are required. Remember, Levo therapy induces neuroplastic changes that may take time and require consistency in the use of stimulation during sleep. Biology is slow, so don’t be discouraged if changes take time to appear.

An initial increase or variability in tinnitus symptoms may indicate the brain’s greater capacity to neuroplastic changes. This means the brain may have a greater reaction to acoustic stimulation and therefore result in more favorable therapeutic outcomes.

It is important to contact your healthcare professional if the type or pitch of your tinnitus changes so that your individualized acoustic recipe (IAR) can be adjusted.

No two people have the same tinnitus sound. Customized acoustic stimulation, the foundation for the Levo system, administers individualized sound therapy based on a patient’s unique sound print. Utilizing an acoustic recipe that specifically matches the patient’s frequency and intensity (loudness)  gives the brain highly accurate guidelines to induce neuroplastic changes.

Non-customized acoustic stimulation uses unmodified noise, music, or environmental sounds as stimulation to improve the adverse physiological and emotional reactions associated with tinnitus by masking the tinnitus.

Neuroplasticity refers to the brain’s ability to adapt and change its structure and function in response to environmental influences. It involves the formation of new neural connections, the modification of existing connections, and the reorganization of neural networks, enabling the brain to adapt, learn, and recover from injuries or changes in its environment.

Levo will provide your healthcare professional with recommended device pricing, however the final cost of your therapy will typically include additional services provided by your healthcare professional. To find out more about the cost of Levo, let us connect you with a Levo preferred provider in your area.

TFI is an evaluation of 8 areas where tinnitus often negatively impacts the quality of life. TFI is an internationally recognized tool that is highly regarded among tinnitus treatment experts. The 8 areas tinnitus often negatively impacts are:

• Intrusiveness
• Sense of Control
• Cognitive
• Sleep
• Auditory
• Relaxation
• Quality of Life
• Emotional

The Levo System is an FDA-cleared device with hardware specifically selected and verified to control the safety and accuracy of the therapy being administered. The therapy has been proven effective only with the hardware provided.

The TFI offers insight into tinnitus severity and how a patient has been negatively impacted by the condition. When used pre- and post- therapy, the TFI can determine how a patient’s quality of life has been changed through use of the Levo System. The TFI is the only tinnitus assessment tool that evaluates sleep — a key area of interest to Levo patients.

Sleep can be one of the most challenging times for tinnitus patients. Levo has been proven to significantly improve the quality of patients sleep. In addition, there are many benefits to administering therapy during sleep:

• Auditory pathways remain active while sleeping. With fewer competing sensor inputs and cognitive demands, neuroplastic response may be enhanced when acoustic stimulation happens during sleep, increasing the effectiveness of the therapy.
• Therapy at night does not interfere with daily activities and because patients are not aware of the stimulation it reduces treatment related anxiety.